Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Imbalance in immune cells causes hair loss in alopecia areata.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Becker's Melanosis and Hypertrichosis mainly affects young males, causing brown skin patches and extra hair on one side of the upper body.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Unable to provide a summary as no conclusion is provided in the text.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Temporary scalp trichopigmentation creates a shaved hair look on the scalp using pigments that fade over time.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.